Detailed TOC of Global mRNA Vaccines & Therapeutics Market Report, Competitive Landscape, Market Size, Regional Status and Prospect
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global mRNA Vaccines & Therapeutics Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 mRNA Vaccines & Therapeutics Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 mRNA Vaccines & Therapeutics Business Mode and Production Process
2.3.1 mRNA Vaccines & Therapeutics Business Mode Analysis
2.3.2 Production Process Analysis
2.4 mRNA Vaccines & Therapeutics Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
2.4.2 Raw Material Cost of mRNA Vaccines & Therapeutics
2.4.3 Labor Cost of mRNA Vaccines & Therapeutics
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2020-2025)
4.2 Global mRNA Vaccines & Therapeutics Sales Volume and Market Share by Manufacturer (2020-2025)
4.3 Global mRNA Vaccines & Therapeutics Price by Manufacturer (2020-2025)
4.4 mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of mRNA Vaccines & Therapeutics, Product Offered and Application
4.7 mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
4.7.1 mRNA Vaccines & Therapeutics Market Concentration Rate
4.7.2 Global Top 3 and Top 6 mRNA Vaccines & Therapeutics Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global mRNA Vaccines & Therapeutics Market Historical Development by Geographic Region (2020-2025)
5.1 Global mRNA Vaccines & Therapeutics Market Historical Sales Volume by Geographic Region (2020-2025)
5.2 Global mRNA Vaccines & Therapeutics Market Historical Revenue by Geographic Region (2020-2025)
5.3 North America mRNA Vaccines & Therapeutics Market Status by Country (2020-2025)
5.3.1 North America mRNA Vaccines & Therapeutics Sales Volume by Country (2020-2025)
5.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
5.3.3 United States mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.3.4 Canada mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.4 Europe mRNA Vaccines & Therapeutics Market Status by Country (2020-2025)
5.4.1 Europe mRNA Vaccines & Therapeutics Sales Volume by Country (2020-2025)
5.4.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
5.4.3 Germany mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.4.4 France mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.4.5 United Kingdom mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.4.6 Spain mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.4.7 Russia mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.4.8 Poland mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.5 Asia Pacific mRNA Vaccines & Therapeutics Market Status by Country (2020-2025)
5.5.1 Asia Pacific mRNA Vaccines & Therapeutics Sales Volume by Country (2020-2025)
5.5.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
5.5.3 China mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.5.4 Japan mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.5.5 South Korea mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.5.6 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.5.7 India mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.5.8 Australia mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.6 Latin America mRNA Vaccines & Therapeutics Market Status by Country (2020-2025)
5.6.1 Latin America mRNA Vaccines & Therapeutics Sales Volume by Country (2020-2025)
5.6.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
5.6.3 Mexico mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.6.4 Brazil mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.7 Middle East and Africa mRNA Vaccines & Therapeutics Market Status by Country (2020-2025)
5.7.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales Volume by Country (2020-2025)
5.7.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2020-2025)
5.7.3 GCC mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
5.7.4 South Africa mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth (2020-2025)
6 Global mRNA Vaccines & Therapeutics Market Historical Development by Product Type (2020-2025)
6.1 mRNA Vaccines & Therapeutics Definition by Type
6.2 Global mRNA Vaccines & Therapeutics Historical Sales Volume by Product Type (2020-2025)
6.3 Global mRNA Vaccines & Therapeutics Historical Revenue by Product Type (2020-2025)
6.4 Global mRNA Vaccines & Therapeutics Historical Price by Product Type (2020-2025)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2025)
6.5.1 Global mRNA Vaccines & Therapeutics Historical Sales Volume, Revenue and Growth Rate of COVID-19 Vaccines (2020-2025)
6.5.2 Global mRNA Vaccines & Therapeutics Historical Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2020-2025)
6.5.3 Global mRNA Vaccines & Therapeutics Historical Sales Volume, Revenue and Growth Rate of Other Prophylactic Vaccines (2020-2025)
6.5.4 Global mRNA Vaccines & Therapeutics Historical Sales Volume, Revenue and Growth Rate of Intratumoral Immuno-Oncology (2020-2025)
7 Global mRNA Vaccines & Therapeutics Market Historical Development by End User (2020-2025)
7.1 Downstream Market Overview
7.2 Global mRNA Vaccines & Therapeutics Historical Sales Volume by End User (2020-2025)
7.3 Global mRNA Vaccines & Therapeutics Historical Revenue by End User (2020-2025)
7.4 Global mRNA Vaccines & Therapeutics Historical Price by End User (2020-2025)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2025)
7.5.1 Global mRNA Vaccines & Therapeutics Historical Sales Volume, Revenue and Growth Rate of Infectious Disease (2020-2025)
7.5.2 Global mRNA Vaccines & Therapeutics Historical Sales Volume, Revenue and Growth Rate of Cancer (2020-2025)
7.5.3 Global mRNA Vaccines & Therapeutics Historical Sales Volume, Revenue and Growth Rate of Others (2020-2025)
8 Leading Companies Profiles
8.1 eTheRNA
8.1.1 eTheRNA Corporation Information
8.1.2 eTheRNA - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.1.3 eTheRNA Performance Analysis (2020-2025)
8.1.4 eTheRNA Business and Markets Served
8.1.5 eTheRNA Recent Developments
8.2 Moderna Therapeutics
8.2.1 Moderna Therapeutics Corporation Information
8.2.2 Moderna Therapeutics - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.2.3 Moderna Therapeutics Performance Analysis (2020-2025)
8.2.4 Moderna Therapeutics Business and Markets Served
8.2.5 Moderna Therapeutics Recent Developments
8.3 Ethris
8.3.1 Ethris Corporation Information
8.3.2 Ethris - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.3.3 Ethris Performance Analysis (2020-2025)
8.3.4 Ethris Business and Markets Served
8.3.5 Ethris Recent Developments
8.4 Translate Bio
8.4.1 Translate Bio Corporation Information
8.4.2 Translate Bio - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.4.3 Translate Bio Performance Analysis (2020-2025)
8.4.4 Translate Bio Business and Markets Served
8.4.5 Translate Bio Recent Developments
8.5 BioNTech
8.5.1 BioNTech Corporation Information
8.5.2 BioNTech - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.5.3 BioNTech Performance Analysis (2020-2025)
8.5.4 BioNTech Business and Markets Served
8.5.5 BioNTech Recent Developments
8.6 Tiba Biotechnology
8.6.1 Tiba Biotechnology Corporation Information
8.6.2 Tiba Biotechnology - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.6.3 Tiba Biotechnology Performance Analysis (2020-2025)
8.6.4 Tiba Biotechnology Business and Markets Served
8.6.5 Tiba Biotechnology Recent Developments
8.7 In-Cell-Art
8.7.1 In-Cell-Art Corporation Information
8.7.2 In-Cell-Art - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.7.3 In-Cell-Art Performance Analysis (2020-2025)
8.7.4 In-Cell-Art Business and Markets Served
8.7.5 In-Cell-Art Recent Developments
8.8 Sangamo Therapeutics
8.8.1 Sangamo Therapeutics Corporation Information
8.8.2 Sangamo Therapeutics - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.8.3 Sangamo Therapeutics Performance Analysis (2020-2025)
8.8.4 Sangamo Therapeutics Business and Markets Served
8.8.5 Sangamo Therapeutics Recent Developments
8.9 CureVac
8.9.1 CureVac Corporation Information
8.9.2 CureVac - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.9.3 CureVac Performance Analysis (2020-2025)
8.9.4 CureVac Business and Markets Served
8.9.5 CureVac Recent Developments
8.10 Argos Therapeutics
8.10.1 Argos Therapeutics Corporation Information
8.10.2 Argos Therapeutics - mRNA Vaccines & Therapeutics Product Portfolio and Specification
8.10.3 Argos Therapeutics Performance Analysis (2020-2025)
8.10.4 Argos Therapeutics Business and Markets Served
8.10.5 Argos Therapeutics Recent Developments
9 Global mRNA Vaccines & Therapeutics Market Forecast by Product Type and End User (2025-2033)
9.1 Global mRNA Vaccines & Therapeutics Market Forecast by Product Type (2025-2033)
9.1.1 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth Rate of COVID-19 Vaccines (2025-2033)
9.1.2 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Cancer Vaccines (2025-2033)
9.1.3 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Other Prophylactic Vaccines (2025-2033)
9.1.4 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Intratumoral Immuno-Oncology (2025-2033)
9.2 Global mRNA Vaccines & Therapeutics Market Forecast by End User (2025-2033)
9.2.1 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Infectious Disease (2025-2033)
9.2.2 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Cancer (2025-2033)
9.2.3 Global mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Others (2025-2033)
10 Global mRNA Vaccines & Therapeutics Market Forecast by Geographic Region (2025-2033)
10.1 Global mRNA Vaccines & Therapeutics Sales Volume and Revenue Forecast by Geographic Region (2025-2033)
10.2 North America mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.2.1 United States mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.2.2 Canada mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3 Europe mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.1 Germany mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.2 France mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.3 United Kingdom mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.4 Spain mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.5 Russia mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.6 Poland mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4 Asia Pacific mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.1 China mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.2 Japan mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.3 South Korea mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.4 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.5 India mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.6 Australia mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5 Latin America mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5.1 Mexico mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5.2 Brazil mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6.1 GCC mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6.2 South Africa mRNA Vaccines & Therapeutics Sales Volume, Revenue Forecast and Growth (2025-2033)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
Download FREE Sample Report
